Lee Hambright
Stock Analyst at Bernstein
(3.30)
# 1,054
Out of 5,131 analysts
37
Total ratings
76.92%
Success rate
8.43%
Average return
Main Sectors:
Stocks Rated by Lee Hambright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Initiates: Outperform | $49 | $42.72 | +14.70% | 1 | Jan 12, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Perform | $97 → $99 | $91.45 | +8.26% | 2 | Jan 9, 2026 | |
| TNDM Tandem Diabetes Care | Maintains: Market Perform | $18 → $25 | $21.35 | +17.10% | 2 | Jan 9, 2026 | |
| SYK Stryker | Maintains: Outperform | $450 → $465 | $361.37 | +28.68% | 4 | Jan 9, 2026 | |
| PODD Insulet | Maintains: Outperform | $410 → $380 | $278.55 | +36.42% | 2 | Jan 9, 2026 | |
| MDT Medtronic | Maintains: Outperform | $111 → $112 | $96.95 | +15.52% | 4 | Jan 9, 2026 | |
| JNJ Johnson & Johnson | Maintains: Market Perform | $193 → $208 | $209.72 | -0.82% | 6 | Jan 9, 2026 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $700 → $740 | $572.75 | +29.20% | 3 | Jan 9, 2026 | |
| DXCM DexCom | Maintains: Outperform | $84 → $86 | $70.98 | +21.16% | 3 | Jan 9, 2026 | |
| ABT Abbott Laboratories | Maintains: Outperform | $150 → $154 | $124.64 | +23.56% | 6 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $92 → $100 | $95.72 | +4.47% | 1 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $132 → $135 | $83.01 | +62.63% | 3 | Mar 16, 2022 |
Medline
Jan 12, 2026
Initiates: Outperform
Price Target: $49
Current: $42.72
Upside: +14.70%
Zimmer Biomet Holdings
Jan 9, 2026
Maintains: Market Perform
Price Target: $97 → $99
Current: $91.45
Upside: +8.26%
Tandem Diabetes Care
Jan 9, 2026
Maintains: Market Perform
Price Target: $18 → $25
Current: $21.35
Upside: +17.10%
Stryker
Jan 9, 2026
Maintains: Outperform
Price Target: $450 → $465
Current: $361.37
Upside: +28.68%
Insulet
Jan 9, 2026
Maintains: Outperform
Price Target: $410 → $380
Current: $278.55
Upside: +36.42%
Medtronic
Jan 9, 2026
Maintains: Outperform
Price Target: $111 → $112
Current: $96.95
Upside: +15.52%
Johnson & Johnson
Jan 9, 2026
Maintains: Market Perform
Price Target: $193 → $208
Current: $209.72
Upside: -0.82%
Intuitive Surgical
Jan 9, 2026
Maintains: Outperform
Price Target: $700 → $740
Current: $572.75
Upside: +29.20%
DexCom
Jan 9, 2026
Maintains: Outperform
Price Target: $84 → $86
Current: $70.98
Upside: +21.16%
Abbott Laboratories
Jan 9, 2026
Maintains: Outperform
Price Target: $150 → $154
Current: $124.64
Upside: +23.56%
Oct 24, 2024
Maintains: Outperform
Price Target: $92 → $100
Current: $95.72
Upside: +4.47%
Mar 16, 2022
Upgrades: Outperform
Price Target: $132 → $135
Current: $83.01
Upside: +62.63%